Literature DB >> 11022399

Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.

S M Dursun1, A Szemis, H Andrews, P Whitaker, M A Reveley.   

Abstract

OBJECTIVE: To compare the efficacy of clozapine with typical antipsychotic drugs in controlling impulsivity and to explore the possible correlation of impulsivity with plasma 5-hydroxytryptamine (5-HT) levels, plasma 5-hydroxyindoleacetic acid (5-HIAA) levels and plasma 5-HT turnover.
DESIGN: Prospective, cross-sectional study open to medication and blinded to biochemical analyses. PARTICIPANTS: Healthy control subjects (n = 24) and 46 inpatients and outpatients meeting the DSM-IV criteria for schizophrenia; 20 were being treated with clozapine and 26 were taking typical antipsychotic drugs.
INTERVENTIONS: All psychotropic drugs other than clozapine or typical antipsychotic drugs were discontinued for at least 5 days and subjects fasted overnight before they were assessed. OUTCOME MEASURES: Coccaro Impulsivity Scale scores, plasma 5-HT levels, 5-HIAA levels and 5-HT turnover.
RESULTS: Patients treated with clozapine and those treated with typical antipsychotics had significantly higher impulsivity scores than the control group, and the mean impulsivity score of the typical antipsychotic group was significantly higher than that of patients treated with clozapine. The mean concentration of 5-HT of the typical antipsychotic group was significantly lower than that of the control group and patients treated with clozapine; however, mean plasma levels of 5-HIAA were significantly higher for the clozapine group than the other 2 groups. 5-HT turnover was significantly higher for the 2 drug-treatment groups than for the control group.
CONCLUSIONS: These results suggest that treatment with clozapine should be considered for patients with schizophrenia who are impulsive and aggressive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022399      PMCID: PMC1407731     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  21 in total

1.  Restraint, seclusion, and clozapine.

Authors:  A R Mallya; P D Roos; K Roebuck-Colgan
Journal:  J Clin Psychiatry       Date:  1992-11       Impact factor: 4.384

2.  Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior.

Authors:  E F Coccaro; P D Harvey; E Kupsaw-Lawrence; J L Herbert; D P Bernstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

3.  Conceptualizing a serotonin trait. A behavioral dimension of constraint.

Authors:  R A Depue; M R Spoont
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Alterations of cerebrospinal fluid 5-hydroxyindoleacetic acid, and total blood serotonin content during clozapine treatment.

Authors:  C M Banki
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

Review 5.  The role of serotonin in schizophrenia.

Authors:  A Bleich; S L Brown; R Kahn; H M van Praag
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

6.  Effect of clozapine on 5-HIAA excretion in urine and CSF of psychotic patients and on serotonin metabolism in rat brain.

Authors:  M Ackenheil; B Blatt; C Lampart
Journal:  Acta Vitaminol Enzymol       Date:  1975

7.  The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital.

Authors:  J J Ratey; C Leveroni; D Kilmer; C Gutheil; B Swartz
Journal:  J Clin Psychiatry       Date:  1993-06       Impact factor: 4.384

8.  Platelet serotonin in subtypes of schizophrenia and unipolar depression.

Authors:  D Mück-Seler; M Jakovljević; Z Deanović
Journal:  Psychiatry Res       Date:  1991-08       Impact factor: 3.222

9.  Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid.

Authors:  E Rydin; D Schalling; M Asberg
Journal:  Psychiatry Res       Date:  1982-10       Impact factor: 3.222

Review 10.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  9 in total

Review 1.  Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing.

Authors:  María Esther Olvera-Cortés; Blanca Erika Gutiérrez-Guzmán; Elisa López-Loeza; J Jesús Hernández-Pérez; Miguel Angel López-Vázquez
Journal:  Exp Brain Res       Date:  2013-08-30       Impact factor: 1.972

2.  Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.

Authors:  Seon-Young Park; Min-Ho Park; Kyoung-Won Yoon; Sung-Bum Cho; Wan-Sik Lee; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

3.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

4.  Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia.

Authors:  Claire Roberts; Panida Winter; Claire S Shilliam; Zoe A Hughes; Christopher Langmead; Peter R Maycox; Lee A Dawson
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

5.  Risk-taking in schizophrenia and controls with and without cannabis dependence.

Authors:  Bernard A Fischer; Robert P McMahon; Deanna L Kelly; Heidi J Wehring; Walter A Meyer; Stephanie Feldman; William T Carpenter; David A Gorelick
Journal:  Schizophr Res       Date:  2014-11-22       Impact factor: 4.939

6.  Impulsivity and risk taking in bipolar disorder and schizophrenia.

Authors:  L Felice Reddy; Junghee Lee; Michael C Davis; Lori Altshuler; David C Glahn; David J Miklowitz; Michael F Green
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

7.  Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome.

Authors:  L A Houghton; W Atkinson; R P Whitaker; P J Whorwell; M J Rimmer
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

8.  Problem and Pathological Gambling in Schizophrenia: Exploring Links with Substance Use and Impulsivity.

Authors:  Rebecca G Fortgang; Rani A Hoff; Marc N Potenza
Journal:  J Gambl Stud       Date:  2018-09

9.  Clozapine Treatment and Cannabis Use in Adolescents with Psychotic Disorders - A Retrospective Cohort Chart Review.

Authors:  Sephora M Tang; Aylar Ansarian; Darren B Courtney
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2017-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.